Experience

• 

  BIOTEKNOLOGIRÅDET

  • Bergen, Hordaland, Norway

  • Senior advisor

    • Apr 2020 - Present
    • Bergen, Hordaland, Norway

• 

  Novo Nordisk

  • Denmark
  • Pharmaceutical Manufacturing
  • 700 & Above Employee

  • Regulatory Affairs Professional, RA Advanced Therapy Medicinal Products (ATMP)

    • Dec 2019 - Apr 2020

    RA Advanced Therapy Medicinal Products is a newly formed department focusing on the development of therapies using new and innovative modalities such as RNA interference and genome editing. During the time I was part of this team, I gained valuable insight into what are the global requirements for the development and approval of advanced medicinal products, with particular focus on US and EU legislation.

  • Regulatory Affairs Clinical Professional, RA Biopharm

    • Sep 2018 - Nov 2019

    haemofilia - regulatory strategy - development projects - clinical trial applications - due diligence -

  • Regulatory Affairs Graduate

    • Sep 2016 - Aug 2018

    During the two-year Regulatory Affairs (RA) graduate program, I have been exposed to various parts of the RA organization in Novo Nordisk, gaining hands-on experience in areas ranging from life cycle management to early drug development. Sept. 2016 - April 2017 RA Clinical – Modern & Human Insulins (HQ, DK)• Insight and experience with Life Cycle Management Activities and the insulin portfolio • Supported label update for the human insulins• Driving and preparing strategic RA documentation for the human insulins May 2017 - Dec 2017 Regulatory Affairs - Latin America (Regional Office, Sao Paulo, Brazil)• Insight and experience with the regulatory environment in Latin America• Driving and conducting strategic projects in Region LATAM, in collaboration with affiliates, International Operations (IO) and HQ. Jan 2018 - Aug 2018 RA Clinical – Obesity Projects (HQ, DK)• Supporting three early development projects within the Obesity therapeutic area• Experience with RA tasks within early drug development, including non-clinical and clinical development

• 

  Biotech Research & Innovation Centre (BRIC), University of Copenhagen

  • Denmark
  • Biotechnology Research
  • 100 - 200 Employee

  • PhD student - Molecular Mechanisms of Disease

    • Jun 2013 - Aug 2016

    During my PhD, I have been working on Epigenetics, answering fundamental questions on how cellular identity is maintained in human cells. This work has been published (Nature Struct. Mol. Biol., 22, 618-626, July 2015), with me as co-shared first author. The paper was highlighted in Nature Struct. Mol. Biol. news and as the editor’s choice in Science (Vol 349, Issue 6250, August 2015).

  • Research Assistant

    • Oct 2012 - May 2013